-+ 0.00%
-+ 0.00%
-+ 0.00%

Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial

Barchart·09/14/2026 07:45:00
Listen to the news

- Enrollment of 239 Patients Meets Upper End of Planned Enrollment Target Range -

- Topline Data Expected in November 2026 -

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.